Clinical trial
A Confirmatory Study to Evaluate the Rhythm Express Wearable System vs. Simultaneous Polysomnography (PSG) for the Diagnosis of Obstructive Sleep Apnea in an Adult Population With Observed or Suspected Atrial Fibrillation, and Are Indicated for Ambulatory Cardiac Monitoring
NCT06907888 is registered in ClinicalTrials.gov with VivaQuant as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Confirmatory Study to Evaluate the Rhythm Express Wearable System vs. Simultaneous Polysomnography (PSG) for the Diagnosis of Obstructive Sleep Apnea in an Adult Population With Observed or Suspected Atrial Fibrillation, and Are Indicated for Ambulatory Cardiac Monitoring
- Lead sponsor
- VivaQuant
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 18, 2024
- Completion date
- June 25, 2025
- Enrollment
- 30 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
atrial fibrillation (paroxysmal), obstructive sleep apnea (osa), palpitations